| PERIOD ENDING | 4-Apr-09 | 3-Jan-09 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 1,133,793 | 1,132,617 | 1,084,136 | 1,135,760 | | Cost of Revenue | 294,495 | 348,437 | 273,926 | 287,691 | | | Gross Profit | 839,298 | 784,180 | 810,210 | 848,069 | | | Operating Expenses | | Research Development | 139,351 | 138,655 | 131,054 | 138,455 | | Selling General and Administrative | 417,675 | 451,824 | 401,325 | 416,261 | | Non Recurring |
-
| 369,338 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 282,272 | (175,637) | 277,831 | 293,353 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (361) | (9,583) | 179 | 81 | | Earnings Before Interest And Taxes | 281,911 | (185,220) | 278,010 | 293,434 | | Interest Expense | 6,951 | 7,343 | 5,120 | 5,121 | | Income Before Tax | 274,960 | (192,563) | 272,890 | 288,313 | | Income Tax Expense | 73,689 | 1,893 | 79,947 | 87,254 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 201,271 | (194,456) | 192,943 | 201,059 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 201,271 | (194,456) | 192,943 | 201,059 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $201,271 | ($194,456) | $192,943 | $201,059 |
|
0.45% Nasdaq 
0.20%
Income Statement
